XSHG
600288
Market cap666mUSD
Oct 09, Last price
10.48CNY
1D
2.64%
1Q
-36.64%
Jan 2017
-30.18%
IPO
20.74%
Name
Daheng New Epoch Technology Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1998 and based in Beijing, China, Daheng New Epoch Technology Inc. operates within China, covering the entire lifecycle of electrical and opto-electro-mechanical products, from their conception and engineering to production, distribution, and post-sale services. Its diverse portfolio features specialized laser processing equipment, sophisticated optoelectronic components, high-precision machinery, advanced optical and communication coatings, and holographic security packaging. The company also supplies medical devices, visual analytics systems, digital broadcasting technology, semiconductor components, automated control systems, computer hardware, software, peripherals, network solutions, and digital media content. Furthermore, Daheng is actively involved in the research and development of satellite-based positioning, command, and dispatch systems, which find critical applications in fields such as law enforcement, finance, logistics, insurance, maritime operations, surveying, and defense. The firm also dedicates resources to the discovery and advancement of new and specialized pharmaceutical products.
Key people
Tao She
Vice President · since 2025
Xueming Wang
Vice Chairman of the Board, Vice President · since 2024
Bei Wang
Secretary of the Board · since 2024
Zhiqiang Chang
Vice President, Director · since 2024
Yongzhi Lu
Chairman of the Board, President · since 2014
Yan Xie
Chief Financial Officer, Vice President, Director · since 2024
Hongshen Yan
Director · since 2025
Rui Dai
Independent Director · since 2021
Yuting Yang
Independent Director · since 2020
Independent Director · since 2024
Headquarters & legal address
北京市海淀区苏州街3号大恒科技大厦北座13层
海淀区, BJ 100000
CN
海淀区, BJ 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||